Critical Drug Interaction: Discontinue Erythromycin or Fluconazole Immediately
Management and Alternative Options
- The Infectious Diseases Society of America recommends that if treating invasive candidiasis, continue fluconazole and switch erythromycin to a non-interacting antibiotic, such as a beta-lactam or fluoroquinolone if appropriate, with echinocandins (caspofungin, micafungin, or anidulafungin) as preferred first-line agents for candidemia 1
- For patients with candidemia, the recommended fluconazole dosing is 800 mg loading dose, then 400 mg daily, which is acceptable for non-critically ill patients with susceptible species, according to the Infectious Diseases Society of America 1
- For dialysis patients, the recommended fluconazole administration is 200 mg after each hemodialysis session, with a 50% dose reduction if GFR <45 mL/min/1.73 m², as suggested by clinical guidelines 2
- Alternative antifungal options include echinocandins, such as caspofungin (70 mg loading, then 50 mg daily), micafungin (100 mg daily), or anidulafungin (200 mg loading, then 100 mg daily), as first-line treatment for invasive candidiasis, according to the Infectious Diseases Society of America 1
- Lipid formulation amphotericin B (3-5 mg/kg daily) is an alternative option if echinocandin resistance or intolerance occurs, as recommended by the Infectious Diseases Society of America 1